Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio-Techne Corp (NASDAQ:TECH)

129.22
Delayed Data
As of Nov 17
 +0.61 / +0.47%
Today’s Change
95.68
Today|||52-Week Range
132.57
+25.66%
Year-to-Date

Today’s Trading

Previous close128.61
Today’s open128.19
Day’s range127.31 - 129.63
Volume115,930
Average volume (3 months)144,747
Market cap$4.8B
Dividend yield0.99%
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-27.50%
Earnings growth (this year)+8.08%
Earnings growth (next 5 years)+10.35%
Revenue growth (last year)+12.82%
P/E ratio66.3
Price/Sales7.83
Price/Book5.08

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.02-0.03%
JUNOJuno Therapeutics In...+0.90+1.56%
BLUEbluebird bio Inc+3.05+1.90%
EXASExact Sciences Corp+0.37+0.63%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$0.91
Annual revenue (last year)$563.0M
Annual profit (last year)$76.1M
Net profit margin13.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles R. Kummeth
CFO, Chief Accounting Officer &
VP-Finance
James T. Hippel
Corporate headquarters
Minneapolis, Minnesota

Forecasts